Torchilin VP - Search Results

1

Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro.

D'Souza GG, Wang T, Rockwell K, Torchilin VP. D'Souza GG, et al. Among authors: torchilin vp. Pharm Res. 2008 Nov;25(11):2567-72. doi: 10.1007/s11095-008-9674-4. Epub 2008 Jul 11. Pharm Res. 2008. PMID: 18618230

2

Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo.

Boddapati SV, D'Souza GG, Erdogan S, Torchilin VP, Weissig V. Boddapati SV, et al. Among authors: torchilin vp. Nano Lett. 2008 Aug;8(8):2559-63. doi: 10.1021/nl801908y. Epub 2008 Jul 9. Nano Lett. 2008. PMID: 18611058

3

Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol.

Patel NR, Hatziantoniou S, Georgopoulos A, Demetzos C, Torchilin VP, Weissig V, D'Souza GG. Patel NR, et al. Among authors: torchilin vp. J Liposome Res. 2010 Sep;20(3):244-9. doi: 10.3109/08982100903347931. J Liposome Res. 2010. PMID: 19883213

4

Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers.

Salmaso S, Pappalardo JS, Sawant RR, Musacchio T, Rockwell K, Caliceti P, Torchilin VP. Salmaso S, et al. Among authors: torchilin vp. Bioconjug Chem. 2009 Dec;20(12):2348-55. doi: 10.1021/bc900369d. Bioconjug Chem. 2009. PMID: 19928843

5

Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery.

Sawant RR, Vaze OS, Rockwell K, Torchilin VP. Sawant RR, et al. Among authors: torchilin vp. Eur J Pharm Biopharm. 2010 Aug;75(3):321-6. doi: 10.1016/j.ejpb.2010.04.010. Epub 2010 Apr 28. Eur J Pharm Biopharm. 2010. PMID: 20433922

6

Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.

Wang T, Petrenko VA, Torchilin VP. Wang T, et al. Among authors: torchilin vp. Mol Pharm. 2010 Aug 2;7(4):1007-14. doi: 10.1021/mp1001125. Mol Pharm. 2010. PMID: 20518562 Free PMC article.

7

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.

Wang T, D'Souza GG, Bedi D, Fagbohun OA, Potturi LP, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. Wang T, et al. Among authors: torchilin vp. Nanomedicine (Lond). 2010 Jun;5(4):563-74. doi: 10.2217/nnm.10.30. Nanomedicine (Lond). 2010. PMID: 20528452 Free PMC article.

8

Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.

Sawant RR, Vaze O, D'Souza GG, Rockwell K, Torchilin VP. Sawant RR, et al. Among authors: torchilin vp. Pharm Res. 2011 Feb;28(2):301-8. doi: 10.1007/s11095-010-0242-3. Epub 2010 Aug 21. Pharm Res. 2011. PMID: 20730558

9

In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein.

Wang T, Kulkarni N, Bedi D, D'Souza GG, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. Wang T, et al. Among authors: torchilin vp. J Drug Target. 2011 Sep;19(8):597-605. doi: 10.3109/1061186X.2010.550920. Epub 2011 Jan 29. J Drug Target. 2011. PMID: 21275826

10

On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters.

Wang T, Kulkarni N, D'Souza GG, Petrenko VA, Torchilin VP. Wang T, et al. Among authors: torchilin vp. Mol Pharm. 2011 Oct 3;8(5):1720-8. doi: 10.1021/mp200080h. Epub 2011 Jul 29. Mol Pharm. 2011. PMID: 21675738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters